Fingerprint
Dive into the research topics of 'Eight-year immunogenicity and safety of interferon beta-1a-Avonex® treatment in patients with multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eight-year immunogenicity and safety of interferon beta-1a-Avonex® treatment in patients with multiple sclerosis
Robert M. Herndon, Richard A. Rudick, Frederick E. Munschauer, Michele K. Mass, Andres M. Salazar, Michael E. Coats, Robert Labutta, John R. Richert, Stanley L. Cohan, Claude Genain, Donald Goodkin, Martin Toal, Katherine Riester
Research output: Contribution to journal › Article › peer-review
59
Scopus
citations